| Zyden Gentec Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530091 |
NSE Symbol : - |
P/E(TTM) : 8.70 |
|
ISIN Demat : INE622B01045 |
Div & Yield% : - |
EPS(TTM) : 0.10 |
|
Book Value(₹) : 2.35 |
Market Cap(₹Cr) : 4.83 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2015 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.17 | 0.17 | 0.17 | 0.17 | 0.19 | 0.19 |
| Total Income | 0.17 | 0.17 | 0.17 | 0.17 | 0.19 | 0.19 |
| Total Expenditure | 0.01 | 0.00 | 0.01 | 0.05 | 0.02 | 0.05 |
| PBIDT | 0.16 | 0.16 | 0.16 | 0.12 | 0.16 | 0.13 |
| Interest | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| PBDT | 0.16 | 0.16 | 0.16 | 0.09 | 0.16 | 0.13 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.06 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.16 | 0.16 | 0.16 | 0.09 | 0.10 | 0.07 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.16 | 0.16 | 0.16 | 0.09 | 0.10 | 0.07 |
| EPS (Unit Curr.) | 0.03 | 0.03 | 0.03 | 0.01 | 0.09 | 0.07 |
| EPS (Adj) (Unit Curr.) | 0.03 | 0.03 | 0.03 | 0.01 | 0.02 | 0.01 |
| Calculated EPS (Unit Curr.) | 0.03 | 0.03 | 0.03 | 0.02 | 0.09 | 0.07 |
| Calculated EPS (Adj) (Unit Curr.) | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.11 | 0.12 | 0.11 | 0.06 | 0.37 | 0.27 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.11 | 0.12 | 0.11 | 0.06 | 0.07 | 0.05 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.11 | 11.11 | 11.11 | 11.11 | 11.11 | 11.11 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 55,562,000.00 | 55,562,000.00 | 55,562,000.00 | 55,562,000.00 | 11,112,100.00 | 10,859,600.00 |
| Public Shareholding (% in Equity) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 97.73 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 300.00 | 252,800.00 |
| Non Encumbered - % in Total Promoters Holding | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.27 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |